Intact Vascular
150 Strafford Avenue, #303
Wayne
Pennsylvania
19087
United States
Tel: 484-253-1048
Fax: 484-253-1047
Website: http://www.intactvascular.com/
Email: info@intactvascular.com
52 articles about Intact Vascular
-
Intact Vascular Sponsors Symposium on Post-Angioplasty Dissections
5/29/2018
Intact Vascular, Inc. announced the schedule of key presentations that will be featured during a symposium sponsored together with Philips at the 19th Annual NCVH Conference in New Orleans on May 31.
-
Intact Vascular Announces Enrollment Completion of the Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial
5/3/2018
Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has completed enrollment.
-
Intact Vascular Announces $20 Million Series C Financing to Fund Company through PMA Approval of the Tack Endovascular System®
4/16/2018
Financing designed to fund the Company through Pre-Market Approval of the Tack Endovascular System for the treatment of post-angioplasty dissections above the knee.
-
Intact Vascular Welcomes TOBA BTK Trial One-Year Clinical Study Results Publication in Catheterization and Cardiovascular Intervention
3/27/2018
Multi-center pilot study focused on collecting data supporting the safety and performance of the Tack Endovascular System® in subjects with Critical Limb Ischemia (CLI) due to vascular disease below the knee.
-
TOBA II BTK Trial Enrollment Ahead of Schedule for the Tack Endovascular System in Below the Knee Disease
1/25/2018
Intact Vascular announced the Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial surpassed the 100 patient milestone, advancing enrollment well ahead of schedule.
-
Intact Vascular: Positive Twenty-Four Month Tack Optimized Balloon Angioplasty ("TOBA") Single Center Results Presented at VEITHsymposium Conference
11/17/2017
The TOBA study enrolled 138 subjects at 13 sites in Europe.
-
Intact Vascular Announces Enrollment Of First European Patient In Tack Optimized Balloon Angioplasty II Below The Knee (TOBA II BTK) Clinical Trial With The Tack Endovascular System
7/18/2017
-
Intact Vascular Release: FDA Approves 6-Month Primary Endpoint For The Tack Endovascular System In Below The Knee Disease
7/10/2017
-
Intact Vascular Adds Howard Rosen To Its Executive Management Team As VP Marketing And Business Development
5/1/2017
-
Intact Vascular Announces Completion Of Enrollment In The Tack Optimized Balloon Angioplasty II (TOBA II) Clinical Trial
3/23/2017
-
Intact Vascular's Tack Optimized Balloon Angioplasty II Below The Knee (TOBA II BTK) Clinical Trial Commences Enrollment With First Implant Of The Tack Endovascular System
2/13/2017
-
Intact Vascular Release: Company's Tack Endovascular System Secures CE Mark For Repair Of Dissections Following Angioplasty Below The Knee
1/17/2017
-
Intact Vascular Closes On Additional Series B Funding To Advance Development Of The Tack Endovascular System For Peripheral Artery Disease Treatment
1/3/2017
-
Intact Vascular Release: FDA Approves TOBA II BTK Pivotal IDE Clinical Study
10/31/2016
-
Intact Vascular Release: TOBA One-Year Clinical Study Results Published In The Journal Of Vascular Surgery
8/15/2016
-
Intact Vascular’s Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial Commences Enrollment With First European Implant Of The Tack Endovascular System
6/2/2016
-
Intact Vascular Release: Positive Six-Month Tack Optimized Balloon Angioplasty Below-The-Knee (TOBA-BTK) Results Presented At LINC 2016
1/26/2016
-
Intact Vascular Announces Conditional FDA Approval For Tack Optimized Balloon Angioplasty II (TOBA II) Study And Enrollment Of First Patients
9/30/2015
-
Intact Vascular Reels In $38.9 Million Series B Financing
5/15/2015
-
Intact Vascular Release: Positive Twelve-Month Tack Optimized Balloon Angioplasty (TOBA) Results Presented At LINC 2015
1/27/2015